Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
07 September 2007 - 6:05AM
PR Newswire (US)
CAMBRIDGE, Mass., Sept. 6 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that management
will present a corporate overview at the upcoming Bear Stearns 20th
Annual Healthcare Conference on Tuesday, September 11th at 2:00
p.m. (EDT) and at the Maxim Group 1st Annual Growth Conference on
Thursday, September 20th at 3:30 p.m. (EDT), both of which are
being held in New York. The live and archived webcasts of the
presentations can be accessed under "Calendar of Events" in the
Idenix Investor Center at http://www.idenix.com/. Please log in
approximately 5-10 minutes before the events to ensure a timely
connection. The archived replays will be available on the Idenix
website for two weeks following the conferences. About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts, is a biopharmaceutical company engaged in the
discovery, development and commercialization of drugs for the
treatment of human viral and other infectious diseases. Idenix's
current focus is on the treatment of infections caused by hepatitis
B virus, hepatitis C virus and human immunodeficiency virus (HIV).
For further information about Idenix, please refer to
http://www.idenix.com/. Idenix Pharmaceuticals' Contacts: Media:
Teri Dahlman (617) 995-9905 Investors: Amy Sullivan (617) 995-9838
DATASOURCE: Idenix Pharmaceuticals, Inc. CONTACT: Media, Teri
Dahlman, +1-617-995-9905, or Investors, Amy Sullivan,
+1-617-995-9838, both of Idenix Pharmaceuticals Web site:
http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Idenix Pharmaceuticals (MM) News Articles